Group One Trading’s Vor Biopharma VOR Stock Holding History

Group One Trading’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,900	Closed	-$266K	–	8598
2026 Q1	$266K	Sell	14,900 -70,100	-82%	-$989K	﹤0.01%	3891
2025 Q4	$1.11M	Sell	85,000 -11,400	-12%	-$212K	﹤0.01%	2786
2025 Q3	$4.7M	Buy	+96,400	New	+$3.88M	0.01%	1534
2025 Q2	–	Sell	-420	Closed	-$6.03K	–	8722
2025 Q1	$6.03K	Hold	420	–	–	﹤0.01%	6567
2024 Q4	$9.32K	Buy	+420	New	+$6.96K	﹤0.01%	6134
2024 Q3	–	Sell	-10	Closed	-$200	–	7426
2024 Q2	$200	Hold	10	–	–	﹤0.01%	6520
2024 Q1	$474	Buy	+10	New	+$439	﹤0.01%	6747

Other funds holding VOR

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Group One Trading's VOR Position: Q2 2026 in Review

Group One Trading reduced its Vor Biopharma (VOR) stake by 67% in Q2 2026, selling an estimated $92.3K and leaving 2,963 shares worth $54.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5338.

Group One Trading first reported a position in VOR in Q4 2023 and has held it in 7 quarters since. The position peaked at $162K in Q1 2026. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

Group One Trading held 2,963 shares of Vor Biopharma worth $54.5K as of Q2 2026.
Group One Trading sold 6,102 Vor Biopharma shares in Q2 2026, an estimated $92.3K.
Vor Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5338 holding.
Group One Trading first reported a position in Vor Biopharma in Q4 2023 and has held it in 7 quarters since.
Group One Trading's Vor Biopharma position peaked at $162K in Q1 2026.
102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.